Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Learn effective ways to automate your financial goals, making saving and investing easier. Simplify your path to financial success.
19,013 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
After more than a month of walkouts, the york nurses union wins a tentative contract with NewYork-Presbyterian that i...
An in-depth look at Warner Bros. Discovery (WBD) earnings, how its streaming ambitions intersect with legacy TV, and ...
A veteran diplomat weighs the odds of regime change in Iran as U.S.-led strikes escalate, warning that history in the...
Micron stock soaring today is more than a quick move. This guide explains the drivers, how to read the memory market ...
Eager for reliable cash from your investments? This guide explains why some dividend stocks hold up over decades, and...
A mid-February 2026 SEC filing shows Bank Hapoalim taking a new position in the FTCS ETF, worth about $14.7 million. ...
Energy Transfer sits at the heart of U.S. energy infrastructure. This guide explains when energy transfer stock right...
Quantum computing could reshape industries, and early investors may gain. This guide breaks down three stocks to watc...
Nasdaq-100 levered ETFs are back in focus as markets swing. While 3x exposure offers amplified moves, daily resets ma...
In uncertain markets, the best consumer staples stocks stand out for their steady demand and reliable dividends. Lear...
Is UPS stock a long-term winner? This guide breaks down the turnaround story, real numbers, and a clear plan for eval...